Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
10.00
+0.18 (1.83%)
At close: Mar 9, 2026, 4:00 PM EDT
9.81
-0.19 (-1.90%)
After-hours: Mar 9, 2026, 4:43 PM EDT
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $188.33 million as of March 9, 2026.
Market Cap
188.33M
Enterprise Value
105.77M
1-Year Change
n/a
Ranking
Category
Stock Price
$10.00
Market Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $188.33M, a decrease of -12.21%. That is a compound annual growth rate of -12.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 183.66M | 16.35% |
| Dec 31, 2025 | 157.85M | -26.42% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeOnc Technologies Holdings | 188.04M |
| ProQR Therapeutics | 187.51M |
| Molecular Partners AG | 187.40M |
| Heron Therapeutics | 182.24M |
| SAB Biotherapeutics | 180.43M |
| Tiziana Life Sciences | 178.67M |
| Cartesian Therapeutics | 178.12M |
| Nkarta | 177.57M |